ORPHENADRINE CITRATE
ORPHENADRINE CITRATE is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: ORPHENADRINE CITRATE; Generic name: ORPHENADRINE CITRATE; Manufacturer: Northwind Health Company, LLC.
| Brand name | ORPHENADRINE CITRATE |
|---|---|
| Generic name | ORPHENADRINE CITRATE |
| Manufacturer | Northwind Health Company, LLC |
| Used for | INDICATIONS AND USAGE Orphenadrine citrate extended-release tablets are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. |
| Dosage | DOSAGE AND ADMINISTRATION Adults Two tablets per day; one in the morning and one in the evening. |
| Warnings | WARNINGS Some patients may experience transient episodes of light-headedness, dizziness or syncope. Orphenadrine may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or driving a motor vehicle; ambulatory patients should therefore be cautioned accordingly. |
| Active ingredient(s) | ORPHENADRINE CITRATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=106be130-b4f8-5ca1-e063-6294a90a1590 |